Personalis Inc PSNL:NASDAQ

Last Price$2.55NASDAQ Previous Close - Last Trade as of 12:59PM ET 11/25/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$2.55 (259)
Ask (Size)$2.77 (6)
Day Low / HighN/A - N/A
Volume86.6 K
  • Latest Stories
  • Commentary and Analysis
--HC Wainwright Adjusts Personalis' Price Target to $13 From $26, Keeps Buy Rating
1:07PM ET 11/03/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--Citigroup Adjusts Price Target on Personalis to $6 From $8, Maintains Buy Rating
12:21PM ET 11/03/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

-- Earnings Flash (PSNL) PERSONALIS Reports Q3 Revenue $14.9M, vs. Street Est of $13.6M
4:01PM ET 11/02/2022 MT Newswires

...

Personalis Collaborates With Duke University, Olink to Study Immunotherapy Response in Gastroesophageal Cancer Patients
12:10PM ET 10/04/2022 MT Newswires

Personalis (PSNL) said Tuesday it is working with Duke University and Olink (OLK) to research the responses to immunotherapy in advanced gastroesophageal...

Personalis Teams Up With BC Cancer for Colorectal, Pancreatic Cancer Project
10:51AM ET 8/15/2022 MT Newswires

Personalis (PSNL) said Monday it has entered a collaboration project with BC Cancer to launch a liquid biopsy-based research use only assay for a study of...

--Citigroup Lowers Personalis' Price Target to $8 From $14, Maintains Buy Rating
3:24PM ET 8/04/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--HC Wainwright Adjusts Personalis' Price Target to $26 From $30, Reiterates Buy Rating
6:58AM ET 8/04/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

-- Earnings Flash (PSNL) PERSONALIS Reports Q2 Revenue $18.2M
4:01PM ET 8/03/2022 MT Newswires

...

Personalis Secures New US Patent for Molecular Residual Disease Detection Technology
4:52AM ET 7/13/2022 MT Newswires

Personalis (PSNL) said Tuesday it has added another patent family to its intellectual property portfolio related to molecular residual disease. The new...

--Citigroup Adjusts Personalis' Price Target to $14 from $18, Keeps Buy Rating
1:21PM ET 5/05/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...